Study Notes on Iron Deficiency Anemia

IRON DEFICIENCY ANEMIA

It is the most frequent form of hypochromic anemia and the most common anemia in medical practice.

DEFINITION

  • Iron-deficiency anemia occurs through an abnormal synthesis of hemoglobin consequent to a marked decline in body iron stores.

  • Iron is an essential element for cellular activity, being part of enzymes and oxygen transporting protein composition.

Physiological Metabolism of Iron in the Body
  • The total amount of iron in the body varies by age and sex.

  • Absorption of iron occurs in the duodenum and jejunum, favored by an acidic medium that maintains iron in the Fe2+ state.

  • A regular diet contains about 15 mg of iron, of which 5-10% is absorbed. Less than 1 mg of iron is excreted daily, indicating that dietary iron alone cannot meet tissue iron requirements during deficiency situations.

  • The majority of functional iron is obtained from the recycling of iron already present in the body rather than through daily absorption.

  • Active iron is not excreted by the liver or kidneys.

  • Iron is lost from the body primarily through epithelial cells, epidermal scaling, the gastrointestinal tract, or female menstrual periods.

  • Hemoglobin contains about 2/3 of human iron.

  • In the blood, iron is transported by transferrin, a protein synthesized by the liver.

  • Iron is stored in macrophages of the reticuloendothelial system. When erythrocytes die, they release iron which passes to erythroblasts in erythropoiesis islands.

  • Excess iron is stored as ferritin.

ETIOLOGY

  • In chronic anemia, iron deficiency occurs after a relatively long period of negative iron balance.

  • Biological and clinical manifestations of anemia occur after depletion of iron stores.

Causes of Iron Deficiency
Increased Iron Losses (Blood)
  • Chronic or repeated losses:
       - Digestive causes:
         - Esophageal varices
         - Gastric or duodenal ulcer
         - Cancer
         - Hiatal hernias
         - Hemorrhoids
         - Ulcerative colitis
         - Colonic diverticulitis
         - Colonic polyposis
         - Hereditary telangiectasia
         - Parasites
         - Meckel diverticulum (in children)
       - Gynecological causes:
         - Menorrhagia
         - Metrorrhagia
         - Hypermenorrhea (in cases of inflammation, fibroids, cancer, hormonal disorders)
       - Urinary causes:
         - Tumors
         - Lithiasis
         - Polyps leading to secondary hematuria
       - Pulmonary causes:
         - Tuberculosis
         - Hemoptysis
         - Bronchiectasis
         - Neoplasms
       - Epistaxis:
         - Abundant or frequent
       - Hemorrhagic syndromes:
         - Platelet disorders
         - Vasculopathy
         - Disorders of coagulation and fibrinolysis
       - Blood donors:
         - Repeated donations without iron prophylaxis
       - Intravascular hemolysis:
         - Seen in paroxysmal nocturnal hemoglobinuria, microangiopathic hemolysis, etc.

Excessive Consumption and/or Insufficient Intake of Iron
  • Growth periods in children and adolescents

  • Pregnant and breastfeeding women.

CLINICAL DIAGNOSIS

  • Onset:
       - Insidious
       - Sequential development from latent iron deficiency to manifest iron deficiency anemia.

  • The iron metabolism compartments (store or use) experience losses over time.

  • Anemic syndrome signs may appear over months or even years.

  • Manifestation state of disease:
       - Iron deficiency leads to depletion of medullary/tissue iron stores.
       - The anemic syndrome becomes manifest gradually.
       - Homeostatic mechanisms may be adequate at first, but eventually become overwhelmed, leading to symptoms from organs suffering from oxygen deprivation.

Affected Organs and Symptoms
Central Nervous System (CNS)
  • Symptoms include morning headache, asthenia, fatigue, diminished intellectual ability, irritability.

  • Severe iron deficiency may lead to migraine and various mental disorders.

Sense Organs
  • Visual disturbances (phosphenes) and hearing disorders (tinnitus).

Cardiovascular System
  • Symptoms include palpitations, tachycardia, hypotension, chest pain (angina-type), worsening of preexisting angina, heart failure.

Physical Signs
  • Pale skin and mucous membranes with a white tinge.

  • Secondary signs caused by tissue iron deficiency:
       - Epithelial changes:
         - Commissural lip abnormalities
         - Hypertrophic glossitis (red tongue), lingual papillae hypertrophy, taste changes, paresthesia
         - Iron deficiency pharyngitis
         - Atrophy of esophageal epithelium (Plummer-Vinson syndrome)
         - Atrophic gastritis with hypochlorhydria
         - Intestinal disorders, including chronic enterocolopathy
       - Changes in skin and appendages:
         - Brittle and dry hair, premature graying, dry and peeling skin
         - Nails: brittle, ridged, appearance of platonychie/koilonychia
       - Other signs:
         - Ozena (nasal mucosal atrophy)
         - Immune deficiency syndrome favoring infections
         - Neurological disorders

Importance of Underlying Disease
  • Always look for signs of underlying diseases that may contribute to iron deficiency anemia.

LABORATORY DIAGNOSIS

  • Complete Blood Count (CBC):
       - Establishes anemia:
         - Low hemoglobin (Hb)
         - Microcytic erythrocytes (low mean corpuscular volume [MCV])
         - Pronounced hypochromia, possibly up to anulocytes (low mean corpuscular hemoglobin [MCH]) as seen on blood smear
         - Normal or slightly low reticulocyte count

  • Iron Metabolism Investigation:
      - Shows iron deficit:
         - Low serum iron (sideremia)
         - High Total Iron Binding Capacity (TIBC) over 360 μg/dl (normal range: 300-350 μg/dl)
         - Low transferrin saturation coefficient, below 16%; calculated as follows:
           TSC=racextFesericimes100TIBCTSC = rac{ ext{Fe seric} imes 100}{TIBC}
         - Low serum ferritin, below 12 ng/ml, indicates depleted body iron stores.
         - High free protoporphyrin in the erythrocyte

  • Bone Marrow Examination:
       - Rich cell smear with a predominance of basophilic and polychromatophilic erythroblasts.
       - Erythroblasts may have a ‘ragged edge’ appearance; sideroblasts should be below 10% (normal range: 40-60%).
       - Absent or decreased macrophage marrow hemosiderin, visible when using Perls' staining, particularly in severe forms of iron deficiency anemia.
       - Study of marrow iron has the highest diagnostic value, showing clear evidence of iron deficiency within the bone marrow.

  • Diagnosis of the Cause of Anemia:
       - This is crucial in iron deficiency anemia and involves a complex protocol of investigations, including gastro-intestinal imaging, endoscopy, colonoscopy, abdominal ultrasound, chest x-ray, and other tests where necessary.

Positive Diagnosis
  • Type and severity of anemia can be classified as follows:
      - Mild: Hb > 10 g%
      - Moderate: Hb = 10-7 g%
      - Severe: Hb < 7 g%

  • Erythrocyte Indexes:
      - Microcytic and hypochromic type with peripheral blood smear supporting the diagnosis.

  • Clinical suspicion:
       - Based on history of disease and physical examination.

  • Confirmation of Anemia:
       - Hemoglobin levels: <12 g% in women and <13 g% in men.

Establishing Iron Deficiency
  • Investigate sideremia, ferritin, TIBC, transferrin saturation coefficient, and the presence of absent sideroblasts in bone marrow (Perls staining).

Differential Diagnosis
  • Iron deficiency anemia (microcytic and hypochromic) must be differentiated from other types of anemia.

Criteria

Iron Deficiency Anemia

Chronic Inflammation

Thalassemia

Sideroblastic Anemia

Sideremia

Low

Low

Normal

High

TIBC

High

High

Low

Normal

Hemoglobin A2

Low

Normal

High

Low

TREATMENT

Prophylactic Treatment
  • Recommended for individuals requiring higher iron intake:
       - Pregnant women
       - Children
       - Patients with gastric surgery or other digestive disorders
       - Universal blood donors (with 2 months interval between donations).

Curative Treatment
  • Hygienic-Dietary Regime:
       - Rest, with limitations on physical activity imposed due to asthenia and fatigue.
       - Balanced diet rich in protein and iron-containing foods (meat, liver).
       - Note: Diet alone is insufficient to restore iron stores.

  • Medications:
       - Administration of iron-containing drugs, either orally or parenterally.
       - Oral Administration:
         - Various preparations exist; preferably taken around one hour before meals (if tolerance issues arise, they can be taken with or after meals).
         - Different formulations vary in terms of iron concentration and chemical form (e.g., ferrous sulfate, etc.).
       - Example: Sorbifer Durules taken twice daily.
       - Parenteral Administration:
         - Indicated in cases of severe iron deficiency anemia (e.g., severe recent hemorrhage), gastric resection, gastroduodenal ulcers, or severe intolerance to oral preparations.
         - Intramuscular Injections:
           - e.g., "Fier Polimaltozat", "Fier Hausmann"
         - Intravenous Use:
           - Venofer (Fe(OH)3-sucrose complex, 5 ml vial equivalent to 100 mg Fe elemental) administered at 1 vial/day in 100 ml saline solution for 5-10 vials; Ferinject (500-1500 mg/dose).

Medication Assessment
  • Monitoring Iron Therapy:
       - Follow-up on hemoglobin (Hb) values.
       - Reticulocyte count: an effective treatment will lead to an acute rise in reticulocyte numbers, termed "reticulocyte crisis"; typically noticed by day 6, peaking on day 10.
       - Absence of this crisis indicates potential misdiagnosis, noncompliance with treatment, or malabsorption of iron.

Duration of Iron Therapy
  • Although Hb typically normalizes within 4-6 weeks after addressing anemia causes, treatment duration averages 6-12 months or longer, necessary for full recovery of iron stores.

Additional Treatments
  • Blood transfusion may be necessary in serious situations involving severe cerebral or cardiac hypoxia.

  • Collaborative treatment of an underlying cause conducted with various specialists (gastroenterologist, gynecologist, surgeon, etc.).

PATIENT MONITORING

  • Monitoring occurs from week 3 of treatment; thereafter, evaluations are monthly or every 2-3 months based on initial disease status.

  • The assessment is conducted via Complete Blood Count (CBC) and other relevant tests depending on patient status.

References

  1. Additional references were indicated by numbered citations in the transcript, which may provide further reading for deeper understanding of the material.